Toward Informed Selection and Interpretation of Clinical Genomic Tests in Prostate Cancer.

Publication/Presentation Date

3-1-2024

Abstract

Clinical genomic testing of patient germline, tumor tissue, or plasma cell-free DNA can enable a personalized approach to cancer management and treatment. In prostate cancer (PCa), broad genotyping tests are now widely used to identify germline and/or somatic alterations in

Volume

8

First Page

2300654

Last Page

2300654

ISSN

2473-4284

Disciplines

Business Administration, Management, and Operations | Health and Medical Administration | Management Sciences and Quantitative Methods

PubMedID

38547422

Department(s)

Administration and Leadership

Document Type

Article

Share

COinS